Gilead Sciences, Inc. GILD
169.32 USD +2.43 (+1.46%)
At closeNov 10, 2026, 4:13 AM EST
167.35 -1.97 -1.16%
Pre-market · Nov 10, 4:13 AM ET
165.99 Day range 170.11
116.88 52-week range 176.58
- YTD
- +37.95%
- 1 year
- +43.31%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 29.44B | 28.75B | 27.12B | 27.28B | 27.30B | |
| 23.21B | 22.50B | 20.62B | 21.62B | 20.70B | |
| 10.02B | 1.66B | 7.61B | 7.33B | 9.92B | |
| 8.51B | 480.00M | 5.67B | 4.59B | 6.22B | |
| 6.78 | 0.38 | 4.50 | 3.64 | 4.93 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 7.56B | 9.99B | 6.08B | 5.41B | 5.34B | |
| 59.02B | 58.99B | 62.13B | 63.17B | 67.95B | |
| 36.41B | 39.75B | 39.38B | 41.96B | 46.89B | |
| 24.94B | 26.71B | 24.99B | 25.23B | 26.70B | |
| 22.70B | 19.33B | 22.83B | 21.24B | 21.07B |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 10.02B | 10.83B | 8.01B | 9.07B | 11.38B | |
| -4.79B | -3.45B | -2.27B | -2.47B | -3.13B | |
| -7.75B | -3.43B | -5.13B | -6.47B | -8.88B | |
| -563.00M | -523.00M | -585.00M | -728.00M | -579.00M | |
| -2.43B | 3.91B | 673.00M | 74.00M | -659.00M |